OncoLens, an Atlanta-based cancer treatment planning software startup, has raised $2.5 million in a Pre-Series A round led by local VC firm BIP Capital. Previous investors Atlanta Technology Angels and the Robbins Fund also participated in the round.
Using software solutions, OncoLens helps cancer centers conduct cancer case reviews and achieve accreditations from several cancer fighting organizations. The company serves integrated delivery networks and hospitals across the country.
Atlanta Business Journal
BIP Capital backs Atlanta cancer treatment planning software startup